Skip to main content

Table 3 Proportions of ESRD according to the histopathological classes

From: Validation of a newly proposed histopathological classification in Japanese patients with anti-neutrophil cytoplasmic antibody-associated glomerulonephritis

Class

1 year after diagnosis

Total follow-up period

Focal

1/46 (2.2%)

2/46 (4.3%)

Crescentic

7/32 (21.9%)

9/32 (28.1%)

Mixed

2/18 (11.1%)

8/18 (44.4%)

Sclerotic

2/6 (33.3%)

4/6 (66.6%)